Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learned.
Clough A, Pitt E, Nelder C, Benson R, McDaid L, Whiteside L, Davies L, Bridge J, Freear L, Chuter R, Berresford J, McPartlin A, Crockett C, Cobben D, Salem A, Faivre-Finn C, Huddart R, Eccles CL. Clough A, et al. Among authors: huddart r. J Med Imaging Radiat Sci. 2024 Aug 16;55(4):101728. doi: 10.1016/j.jmir.2024.101728. Online ahead of print. J Med Imaging Radiat Sci. 2024. PMID: 39153404 Free article.
Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10).
Siefker-Radtke AO, Huddart RA, Bilen MA, Balar A, Castellano D, Sridhar SS, De Giorgi U, Penkov K, Vasiliev A, Peer A, Järvinen R, Harputluoğlu H, Koshkin VS, Poushnejad S, Wang T, Qureshi A, Tagliaferri MA, Zalevsky J, Loriot Y. Siefker-Radtke AO, et al. Among authors: huddart ra. Urol Oncol. 2024 Oct 29:S1078-1439(24)00671-9. doi: 10.1016/j.urolonc.2024.09.030. Online ahead of print. Urol Oncol. 2024. PMID: 39477771
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial.
Huddart R, Hafeez S, Griffin C, Choudhury A, Foroudi F, Syndikus I, Hindson B, Webster A, McNair H, Birtle A, Varughese M, Henry A, McLaren DB, Parikh O, Nikapota A, Tang C, Patel E, Miles E, Warren-Oseni K, Kron T, Hill C, Philipps L, Vassallo-Bonner C, Cheung KC, Gribble H, Lewis R, Hall E. Huddart R, et al. Eur Urol. 2024 Sep 24:S0302-2838(24)02596-X. doi: 10.1016/j.eururo.2024.09.006. Online ahead of print. Eur Urol. 2024. PMID: 39379236 Free article.
Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.
Dinh PC Jr, Monahan PO, Fung C, Sesso HD, Feldman DR, Vaughn DJ, Hamilton RJ, Huddart R, Martin NE, Kollmannsberger C, Althouse S, Einhorn LH, Frisina R, Root JC, Ahles TA, Travis LB. Dinh PC Jr, et al. Among authors: huddart r. JNCI Cancer Spectr. 2024 Sep 2;8(5):pkae068. doi: 10.1093/jncics/pkae068. JNCI Cancer Spectr. 2024. PMID: 39141447 Free PMC article.
Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study.
Hafeez S, Warren-Oseni K, Jones K, Mohammed K, El-Ghzal A, Dearnaley D, Harris V, Khan A, Kumar P, Lalondrelle S, McDonald F, Tan M, Thomas K, Thompson A, McNair HA, Hansen VN, Huddart RA. Hafeez S, et al. Among authors: huddart ra. Int J Radiat Oncol Biol Phys. 2024 Jul 26:S0360-3016(24)03137-7. doi: 10.1016/j.ijrobp.2024.07.2317. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39069239 Free article.
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer.
Webster A, Francis M, Gribble H, Griffin C, Hafeez S, Hansen VN, Lewis R, McNair H, Miles E, Hall E, Huddart R; RAIDER Trial Management Group. Webster A, et al. Among authors: huddart r. Radiother Oncol. 2024 Oct;199:110460. doi: 10.1016/j.radonc.2024.110460. Epub 2024 Jul 26. Radiother Oncol. 2024. PMID: 39069085 Free PMC article.
393 results